Grail (GRAL) Competitors $17.42 +0.01 (+0.06%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends GRAL vs. WGS, ARDT, ADUS, PACS, PGNY, TDOC, FTRE, NHC, VRDN, and AHCOShould you be buying Grail stock or one of its competitors? The main competitors of Grail include GeneDx (WGS), Ardent Health Partners (ARDT), Addus HomeCare (ADUS), PACS Group (PACS), Progyny (PGNY), Teladoc Health (TDOC), Fortrea (FTRE), National HealthCare (NHC), Viridian Therapeutics (VRDN), and AdaptHealth (AHCO). These companies are all part of the "healthcare" industry. Grail vs. GeneDx Ardent Health Partners Addus HomeCare PACS Group Progyny Teladoc Health Fortrea National HealthCare Viridian Therapeutics AdaptHealth Grail (NASDAQ:GRAL) and GeneDx (NASDAQ:WGS) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, dividends, institutional ownership, profitability, valuation and community ranking. Which has better earnings and valuation, GRAL or WGS? Grail has higher earnings, but lower revenue than GeneDx. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGrailN/AN/AN/AN/AN/AGeneDx$202.57M9.42-$175.77M-$3.11-22.34 Is GRAL or WGS more profitable? Grail has a net margin of 0.00% compared to GeneDx's net margin of -31.25%. Grail's return on equity of 0.00% beat GeneDx's return on equity.Company Net Margins Return on Equity Return on Assets GrailN/A N/A N/A GeneDx -31.25%-13.35%-6.91% Does the MarketBeat Community believe in GRAL or WGS? GeneDx received 11 more outperform votes than Grail when rated by MarketBeat users. Likewise, 50.00% of users gave GeneDx an outperform vote while only 0.00% of users gave Grail an outperform vote. CompanyUnderperformOutperformGrailOutperform VotesNo VotesUnderperform Votes3100.00% GeneDxOutperform Votes1150.00% Underperform Votes1150.00% Does the media favor GRAL or WGS? In the previous week, GeneDx had 4 more articles in the media than Grail. MarketBeat recorded 14 mentions for GeneDx and 10 mentions for Grail. GeneDx's average media sentiment score of 0.36 beat Grail's score of 0.30 indicating that GeneDx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Grail 1 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral GeneDx 3 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders & institutionals have more ownership in GRAL or WGS? 61.7% of GeneDx shares are owned by institutional investors. 27.3% of GeneDx shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Do analysts rate GRAL or WGS? Grail presently has a consensus price target of $16.00, suggesting a potential downside of 8.15%. GeneDx has a consensus price target of $70.67, suggesting a potential upside of 1.71%. Given GeneDx's stronger consensus rating and higher possible upside, analysts plainly believe GeneDx is more favorable than Grail.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Grail 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00GeneDx 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 SummaryGeneDx beats Grail on 10 of the 13 factors compared between the two stocks. Get Grail News Delivered to You Automatically Sign up to receive the latest news and ratings for GRAL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRAL vs. The Competition Export to ExcelMetricGrailMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$585.31M$2.96B$5.36B$9.13BDividend YieldN/A16.03%5.13%4.03%P/E RatioN/A15.3489.4717.33Price / SalesN/A200.681,264.56137.35Price / CashN/A426.0143.7535.97Price / BookN/A4.925.324.80Net IncomeN/A-$33.85M$122.60M$224.91M7 Day Performance-1.75%1.54%0.69%1.77%1 Month Performance-26.25%-4.33%1.55%2.22%1 Year PerformanceN/A10.49%27.25%20.67% Grail Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRALGrail0.3618 of 5 stars$17.42+0.1%$16.00-8.2%N/A$584.83M$117.67M0.001,360Short Interest ↑News CoverageWGSGeneDx1.5449 of 5 stars$83.91-6.1%$70.67-15.8%+1,949.8%$2.31B$267.23M-26.981,200Gap UpARDTArdent Health PartnersN/A$16.11+2.0%$22.00+36.6%N/A$2.30B$5.71B0.0024,200Lockup ExpirationADUSAddus HomeCare4.6872 of 5 stars$126.57+1.0%$133.67+5.6%+49.0%$2.30B$1.13B28.9633,200Analyst DowngradeNews CoveragePositive NewsPACSPACS Group3.8616 of 5 stars$13.26+3.4%$34.00+156.4%N/A$2.02B$3.56B0.0032,433PGNYProgyny3.9815 of 5 stars$20.31+8.3%$25.00+23.1%-46.2%$1.73B$1.14B35.02310Analyst RevisionNews CoverageTDOCTeladoc Health3.2676 of 5 stars$9.61-2.6%$12.24+27.3%-54.6%$1.65B$2.59B-1.675,600FTREFortrea3.4861 of 5 stars$18.18-0.1%$23.30+28.2%-43.0%$1.63B$2.98B-5.3218,000Insider TradeShort Interest ↑NHCNational HealthCareN/A$97.27+0.4%N/AN/A$1.50B$1.23B12.1912,400VRDNViridian Therapeutics2.0741 of 5 stars$17.79-2.3%$35.70+100.7%-22.8%$1.41B$302,000.00-4.1350Short Interest ↑Positive NewsAHCOAdaptHealth3.6359 of 5 stars$10.30+1.6%$12.40+20.4%+56.1%$1.39B$3.26B-6.2410,700Short Interest ↓Positive News Related Companies and Tools Related Companies GeneDx Alternatives Ardent Health Partners Alternatives Addus HomeCare Alternatives PACS Group Alternatives Progyny Alternatives Teladoc Health Alternatives Fortrea Alternatives National HealthCare Alternatives Viridian Therapeutics Alternatives AdaptHealth Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:GRAL) was last updated on 1/17/2025 by MarketBeat.com Staff From Our PartnersI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Grail, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Grail With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GRAL Stock Alerts